drugset / Trial / NCT04278651

Early Antenatal Support for Iron Deficiency Anemia

NCT04278651

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a randomized, controlled multi-site trial of iron therapy in pregnancy. The purpose of this research is to see if second trimester initiation of intravenous (IV) iron therapy is better than oral iron therapy for treatment of anemia in pregnancy by improving blood count, quality of life and reducing side effects.

Timeline

Start
2021-09-29
Primary completion
2026-08-30
Completion
2026-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferrous Sulfate Diagnostic / imaging agent 325 mg Oral
Subject Ferumoxytol Diagnostic / imaging agent 510 mg Intravenous